ING THINK
India: from generics giant to innovation powerhouse?
ASIA/PACIFIC: India is the most dominant generics manufacturer in the world. Given the increased importance and complexity of generics and the recent free trade deal with the EU, the sector’s outlook is bright. However, India’s push into innovation is unlikely to lead to blockbus
Desk synthesis pending
We’re writing the institutional analysis for this note — multi-section body, firm-by-firm alignment chips, key takeaways, market implications, risks. The synthesizer processes the queue hourly, with priority by citation density.
In the meantime, the most useful reads are the related coverage and primary source below — both reach the same substance from different angles.
Sources & References
How we cover this story